#ColonCancer awareness at the wellness event @MedStarGUH. Go get screened! @MedStarHealth

IN PRESS: review in @TransplantJrnl (w/our S. Siddiqui) on impact of pretransplant #DM in #LT: analysis reveals pre-LT DM is a significant predictor of post-LT cardiovascular events and end-stage renal disease. @ChengHanNg #Livertwitter @VCUTransplant https://t.co/5nBGX6CZXk

👁️ The institute's Shadab Siddiqui in the @nash24x7 video on post-transplant management of the #MASLD patient. https://t.co/FncnEmQfzf #livertwitter #liver @VCUTransplant #livertransplant

#LiverTwitter #GITwitter Happy to share our latest paper accepted in @TransplantJrnl on the impact of Pretransplant #DM in #LT! Globally, preLT #DM occurs in ~1/4 of the population; are we doing enough to reduce the risk of mortality? @VCU @VCU_Liver https://t.co/bNw17GFpBN

#LiverTwitter 🔥 From @TheLiverFound, the latest episode of The Liver Lounge Podcast shares the implications of #NASH/#MASH in #livertransplantation (#LT) with Prof Shadab @VCU_Liver! Listen today on any podcast app! 🎧 https://t.co/MBHB9RMEPA 📷 https://t.co/CNgABzNBWv

🆕Article in press❕ Natural history of NASH #cirrhosis in #livertransplant waitlist registrants Read it here👉 https://t.co/5SMJH7KXKs @WenHuiLim4 #LiverTwitter

🆕Article in press @JHeptaology by @NUSingapore and @VCU_Liver researchers. Natural history of# NASH #cirrhosis in #livertransplant waitlist registrants Read it here👉 https://t.co/txoZO1X0cO @WenHuiLim4 @VCUTransplant #LiverTwitter

Amazing time taking @ASGEendoscopy course with my @GeorgetownGI co-fellows! Glad to also catch up with @AASLDFoundation old friends @HZaverMD @RahulKarnaMD.

What a great learning experience at @ASGEendoscopy First Year Fellows Course! I even got to catch up with some of my @AASLDFoundation ELS Co-Scholars @mikethtseng and @RahulKarnaMD! Thank you @uvagastro for sending us.

Inspired by the amazing #FirstYearFellows & the inspiring co-faculty Learned more than could have possibly taught Thanks @ASGEendoscopy @ChahalPrabhleen @mswaghden for a 🔥course @ShivangiKMD @Mo_Abousaleh @JenKolbMD @NCosgroveMD @BrookeGlessing @SiddikiGI @SchlachtermanMD

#liverTwitter ❗️Excited to share our latest study on the impact of #Donor #steatosis & #diabetes on #LT outcomes based on aetiology of #cirrhosis. 🔥Results in 13% increase risk of mortality and 16% increase risk of graft failure! Should we be concern? https://t.co/dJaSefwcbw

#LiverTwitter 🚨🔥🔥 Sharing our study published in @JHepatology on the natural history of #NASH on LT waitlist ➡️ significant higher risk of mortality on waitlist ➡️ lower rate of LT ➡️ creatinine was the largest driver of MELD https://t.co/HqJlV5Khc4

#LiverTwitter #GITwitter Premier into upcoming paper recently accepted by the journal of hepatology presented by Shadab @VCU_Liver in Singapore Hepatology Conference! 😂😍 @WenHuiLim4 @DrMarkMuthiah @DrHuangDQ @wong_yujun @MLPTeng @mikethtseng

Ethnic disparities in waitlist outcomes of non-alcoholic steatohepatitis patients listed for liver transplantation in the United States

Hello to all medical students or doctors ! I am Oscar, a UK junior doctor. Join ResearchLabX and get expert guidance and support in meta-analysis, epidemiology, and cohort studies. Connect with us at https://t.co/NQKcoW10su and take your research to the next level!

What’s new in the Liver this week? @RoundsLiver summarizes it for you! @DrHuangDQ @mikethtseng @KarnJUVE @Apichatka @wong_yujun @DrMarkMuthiah @DarrenTanJH @WenHuiLim4

#GITwitter #LiverTwitter We recently evaluated the risk of metabolic syndrome after #LT at @LTxJournal. MS affected 1/3 of LT recipients, and 60% of NAFLD individuals. MS after #LT also significantly increase the risk of #CVD events. https://t.co/ScCcCUYxDt